Massmedica S.A. (WSE:MSM)
Poland · Delayed Price · Currency is PLN 5.70
+0.42 (7.95%)
At close: Sep 9, 2026
Massmedica Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 0.62 | 0.54 | 0.6 | 0.51 | 0.41 | 0.35 |
Depreciation & Amortization | 0.5 | 0.48 | 0.54 | 0.28 | 0.59 | 0.38 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.04 |
Other Operating Activities | 0.66 | 0.6 | 0.51 | 0.42 | 0.32 | - |
Change in Accounts Receivable | -3.9 | -4.75 | 3.66 | -0.79 | -1.4 | 0.05 |
Change in Inventory | 4.22 | 0.26 | -3.85 | -1.37 | -0.24 | -1.7 |
Change in Other Net Operating Assets | -3.22 | 0.96 | 0.15 | 0.46 | 0.51 | -0.49 |
Operating Cash Flow | -1.13 | -1.92 | 1.61 | -0.49 | 0.19 | -1.37 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.15 | -0.24 | -1.75 | -0.07 | -0.12 | -0.32 |
Sale (Purchase) of Real Estate | - | - | - | - | - | -0.48 |
Investment in Securities | - | - | - | - | 0.03 | - |
Investing Cash Flow | -1.15 | -0.24 | -1.75 | -0.07 | -0.09 | -0.79 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 3.03 | 1.36 | 0.9 | 0.57 | 2.17 |
Total Debt Issued | 2.75 | 3.03 | 1.36 | 0.9 | 0.57 | 2.17 |
Short-Term Debt Repaid | - | - | -0.67 | - | - | - |
Total Debt Repaid | - | - | -0.67 | - | - | - |
Net Debt Issued (Repaid) | 2.75 | 3.03 | 0.7 | 0.9 | 0.57 | 2.17 |
Issuance of Common Stock | 0.84 | 0.81 | 0.51 | 0.41 | 0.01 | - |
Common Dividends Paid | - | - | - | - | -0.35 | - |
Other Financing Activities | -1.66 | -1.55 | -1.02 | -0.83 | -0.32 | - |
Financing Cash Flow | 1.93 | 2.3 | 0.19 | 0.48 | -0.09 | 2.17 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -0.34 | 0.14 | 0.05 | -0.09 | 0.01 | 0.01 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.28 | -2.16 | -0.14 | -0.57 | 0.07 | -1.69 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -7.16% | -6.69% | -0.42% | -2.15% | 0.29% | -7.82% |
Free Cash Flow Per Share | -0.94 | -0.89 | -0.06 | -0.23 | 0.03 | -0.70 |
Levered Free Cash Flow | -0.99 | -2.91 | -0.35 | -3.05 | -1.08 | -1.95 |
Unlevered Free Cash Flow | -0.63 | -2.53 | -0.09 | -3.04 | -1.07 | -1.92 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.57 | 0.6 | 0.51 | 0.42 | 0.32 | - |
Change in Working Capital | -2.9 | -3.54 | -0.04 | -1.7 | -1.13 | -2.14 |